Search - tctmd.com

Displaying 141 - 160 of 167

Sort: Relevancy | Date

News Daily News

Link Between Migraines and Cardiovascular Disease Strengthened by Nurses’ Health Study II Analysis

L.A. McKeown

June 02, 2016

News Daily News

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

Caitlin E. Cox

May 12, 2016

News Daily News

Dying on the Weekend? Not So Fast, Say Two Studies Examining Hospital Care on Saturdays, Sundays

Todd Neale

May 12, 2016

News Daily News

Another Study Linking Night Shifts to Increased CHD Offers Insights Into Dose-Response

L.A. McKeown

April 26, 2016

News Daily News

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

L.A. McKeown

April 21, 2016

News Daily News

Survey Adds To Mounting Evidence That Cath Lab Work Has Radiation-Related Health Effects

L.A. McKeown

April 14, 2016

News Conference News ACC 2016

Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money

Caitlin E. Cox

April 04, 2016

News Daily News

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

L.A. McKeown

December 09, 2015

News Industry News

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

November 03, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Industry News

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

October 20, 2015

News Industry News

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

August 06, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

Todd Neale

April 17, 2015

News Daily News

US Regional Variability Seen in Incidence, Outcomes of In-Hospital Cardiac Arrest

April 03, 2015

News Daily News

Survey Puts Spotlight on Physical Stress of Working in a Cath Lab

February 25, 2015

News Daily News

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

Yael L. Maxwell

August 07, 2014

News Industry News

CardioMEMS Receives FDA Approval for Heart Failure Treatment

May 28, 2014

Advertisement

Link Between Migraines and Cardiovascular Disease Strengthened by Nurses’ Health Study II Analysis

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

Dying on the Weekend? Not So Fast, Say Two Studies Examining Hospital Care on Saturdays, Sundays

Another Study Linking Night Shifts to Increased CHD Offers Insights Into Dose-Response

Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends

Survey Adds To Mounting Evidence That Cath Lab Work Has Radiation-Related Health Effects

Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations

AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

Pharmacists May Help Ameliorate Substantial Variation in Dabigatran Adherence

US Regional Variability Seen in Incidence, Outcomes of In-Hospital Cardiac Arrest

Survey Puts Spotlight on Physical Stress of Working in a Cath Lab

Regional Quality-Improvement Effort Reduces Contrast-Induced AKI After PCI

CardioMEMS Receives FDA Approval for Heart Failure Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content